TechValidate Research on Nozin

Nozin Customer Experience

Meritus Health


This case study of Meritus Health is based on a September 2019 survey of Nozin customers by TechValidate, a 3rd-party research service.

“Based on initial findings Nasal Decolonization protocols have effectively decreased isolation days while simultaneously cutting isolation costs and improving patient satisfaction.”


Meritus Health evaluated and ultimately selected a Nozin infection prevention program to address concerns with the following:

  • Infection prevention
  • Effectiveness of MRSA surveillance
  • Better antibiotic stewardship
  • Operational efficiencies (i.e., patient flow or throughput)
  • Costs

Use Case

Nozin® Nasal Sanitizer® antiseptic is applied to the following populations:

  • ICU patients
  • MRSA colonized patients
  • High risk area patients (history, dialysis, etc)
  • Pre-op patients
  • Post-op patients


Since implementing the Nozin infection prevention program, Meritus Health has achieved the following results:

  • Responsible reduction of MRSA Contact Precautions
  • Less time donning and doffing PPE
  • Increased patient satisfaction
  • Increased staff satisfaction
  • Improved antibiotic stewardship
  • Cost savings
  • Reduced pathogen burden

About This Data

This data was sourced directly from verified users of Nozin by TechValidate.

TechValidate verifies the identity and organizational affiliation of all participants that contribute to published research data. When research participants so desire, we also guarantee their anonymity so that they may share information honestly and freely.

More Research on Nozin